search icon
  • Print
  • ShareThis
  • Text Size

RSS Feed Print Category View
J&J wins FDA panel blessing for hep C blockbuster hopeful
ThomasKim
Posted: Friday, October 25, 2013 2:32 PM
Joined: 2/20/2013
Posts: 39


"Johnson & Johnson's much-hyped simeprevir picked up the unanimous support of FDA advisers on Thursday, moving the potential hepatitis C blockbuster one step closer to market as a who's who of drug developers advances next-generation therapies."

To read more, please visit: J&J wins FDA panel blessing for hep C blockbuster hopeful - FierceBiotech http://www.fiercebiotech.com/story/jj-wins-fda-panel-blessing-hep-c-blockbuster-hopeful/2013-10-24#ixzz2ilBCwbF6
 

| HIVMA | Contact Us

© Copyright IDSA 2014 Infectious Diseases Society of America

Full Site Mobile Site